REACH Genetics, Inc.
company.status.inactiveCIK 1657737fmd_043P1J8G5YHJKQG4AEC6KPA33BAgriculture, Forestry and Fishing · Agricultural Production-CropsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 5 periods
Latest annual · FY2017
Millions- Net income
- (1)
Latest quarter · Q4 FY2017
Millions- Net income
- (1)
REACH Genetics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Net income | -$686,829 | -$63,539 | 10-K 2018-05-04 · proof | |
| Cash from operating activities | -$205,539 | -$63,499 | 10-K 2018-05-04 · proof | |
| Total assets | $3.4 million | $301 | +1,138,773.4% | 10-K 2018-05-04 · proof |
| Total liabilities | $3.9 million | $1,722 | +223,645.9% | 10-K 2018-05-04 · proof |
| Cash and cash equivalents | $21,992 | $301 | +7,206.3% | 10-K 2018-05-04 · proof |
- What was REACH Genetics, Inc.'s net income in fiscal 2017?
- REACH Genetics, Inc. reported net income of -$686,829 for fiscal 2017 (the year ended Dec 31, 2017), against -$63,539 the year before. Source: the 10-K filed with the SEC on May 4, 2018. SEC
- What was REACH Genetics, Inc.'s cash from operating activities in fiscal 2017?
- REACH Genetics, Inc. reported cash from operating activities of -$205,539 for fiscal 2017 (the year ended Dec 31, 2017), against -$63,499 the year before. Source: the 10-K filed with the SEC on May 4, 2018. SEC
- What are REACH Genetics, Inc.'s total assets?
- As of Dec 31, 2017, REACH Genetics, Inc. reported total assets of $3.4 million, against $301 a year earlier (+1,138,773.4%). Source: the 10-K filed with the SEC on May 4, 2018. SEC
- What are REACH Genetics, Inc.'s total liabilities?
- As of Dec 31, 2017, REACH Genetics, Inc. reported total liabilities of $3.9 million, against $1,722 a year earlier (+223,645.9%). Source: the 10-K filed with the SEC on May 4, 2018. SEC
- What are REACH Genetics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2017, REACH Genetics, Inc. reported cash and cash equivalents of $21,992, against $301 a year earlier (+7,206.3%). Source: the 10-K filed with the SEC on May 4, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1657737&period_type=annual&limit=5"Information only, not investment advice.